Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs

Author： Hermann Matthias Ruschitzka Frank

ISSN： 0785-3890

Source： Annals of Medicine, Vol.39, Iss.1, 2007-01, pp. : 18-27

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of non‐steroidal anti‐inflammatory drugs and risk of chronic kidney disease in people with Type 2 diabetes mellitus, a nationwide longitudinal cohort study

DIABETIC MEDICINE, Vol. 32, Iss. 3, 2015-03 ,pp. : 382-390

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐steroidal anti‐inflammatory drugs and the risk of head and neck cancer: A case‐control analysis

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 10, 2015-11 ,pp. : 2424-2431

John Wiley & Sons Inc

Access to resources Recommend Favorite

Risk of ischemic stroke associated with non‐steroidal anti‐inflammatory drugs and paracetamol: a population‐based case‐control study

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 708-718

John Wiley & Sons Inc

Access to resources Recommend Favorite

Non‐steroidal anti‐inflammatory drugs increase the risk of mucosal injuries but not of overt small bowel bleeding

DIGESTIVE ENDOSCOPY, Vol. 30, Iss. 1, 2018-01 ,pp. : 48-49

John Wiley & Sons Inc

Access to resources Recommend Favorite

Issues in the Treatment of Ankylosing Spondylitis with Non-Steroidal Anti-Inflammatory Drugs

By van der Linden Sjef

Wiener Medizinische Wochenschrift, Vol. 158, Iss. 7-8, 2008-05 ,pp. : 195-199

Springer Publishing Company

Access to resources Recommend Favorite